Case Study: Rubius Therapeutics achieves streamlined, collaborative cell engineering with Benchling

Optimizing Cell Engineering with a Unified Informatics Platform

Rubius Therapeutics engineers red blood cell therapeutics (RCTs) to treat cancer, autoimmune diseases, and rare enzyme deficiencies. The company struggled with disorganized manual record keeping, scattered donor and experimental data, inefficient request-management workflows, and decentralized information that made engineering processes hard to track and cross-team collaboration difficult.

By adopting Benchling as a unified informatics platform, Rubius centralized sequence and registry data, linked upstream and downstream experimental records, and used Benchling Requests and Workflows to structure queues, track experiment status, and manage the full RCT pipeline in real time. The result was improved cross-team collaboration with interlinked experimental context, seamless request tracking and forecasting, and a more efficient, iteratable cell engineering process that sped project progress.

Rubius Therapeutics

Tiffany Chen

Director of Discovery